Bio Rad Laboratories Inc/ US0905722072 /
| 18/11/2024 22:10:00 | Chg. -7.16 | Volume | Bid12:04:47 | Ask12:04:47 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 313.15USD | -2.24% | 311,967 Turnover: 52.41 mill. |
125.26Bid Size: 200 | 497.90Ask Size: 100 | 7.18 bill.USD | - | - |
Assets
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 508.6900 | 499.3390 | 491.3710 | 490.9520 | 498.6120 | ||||||
| Intangible Assets | 133.1230 | 145.5000 | 199.5000 | 253.9000 | 332.1000 | ||||||
| Long-Term Investments | 2,655.7090 | 4,638.2050 | 9,561.1400 | 14,387.0060 | 8,830.8920 | ||||||
| Fixed Assets | 3,587.6220 | 5,828.7450 | 10,832.7650 | 15,786.7120 | 10,343.7240 | ||||||
| Inventories | 583.8150 | 554.0070 | 622.2530 | 572.2390 | 719.3000 | ||||||
| Accounts Receivable | 392.4430 | 392.6720 | 419.4240 | 423.5370 | 494.6450 | ||||||
| Cash and Cash Equivalents | 431.5260 | 660.6720 | 662.2050 | 470.7830 | 434.2150 | ||||||
| Current Assets | 2,023.4780 | 2,180.1550 | 2,139.8350 | 1,989.0880 | 3,157.9760 | ||||||
| Total Assets | 5,611.1000 | 8,008.9000 | 12,972.6000 | 17,775.8000 | 13,501.7000 | ||||||
Liabilities
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 122.4500 | 107.0140 | 139.4510 | 141.9410 | 135.0410 | ||||||
| Long-term debt | 438.9000 | 13.6000 | 12.3000 | 10.5000 | 1,197.7160 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 553.2000 | 997.8000 | - | - | - | ||||||
| Liabilities | 1,590.7690 | 2,253.8430 | 3,092.6600 | 4,108.6660 | 3,886.4480 | ||||||
| Share Capital | .0020 | .0020 | .0020 | .0020 | .0020 | ||||||
| Total Equity | 4,020.3310 | 5,755.0570 | 9,879.9400 | 13,667.1340 | 9,615.2520 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 5,611.1000 | 8,008.9000 | 12,972.6000 | 17,775.8000 | 13,501.7000 | ||||||
Income Statement
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,289.4150 | 2,311.6590 | 2,545.6260 | 2,922.5450 | 2,802.2490 | ||||||
| Depreciation (total) | 138.1000 | 134.2000 | - | - | - | ||||||
| Operating Result | -103.3410 | 229.6610 | 410.9570 | 489.4300 | 482.6160 | ||||||
| Interest Income | -23.9620 | -23.4160 | -21.8610 | -1.5510 | -38.1140 | ||||||
| Income Before Taxes | 512.7000 | 2,261.1000 | 4,907.6000 | 5,438.1000 | -4,704.3000 | ||||||
| Income Taxes | -147 | -502.4000 | -1,101.4000 | -1,192.2000 | 1,076.7000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 365.6000 | 1,758.7000 | 3,806.2670 | 4,245.9020 | -3,627.5350 | ||||||
Per Share
Cash Flow
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 285.5000 | 457.9000 | 575.3000 | 656.5000 | 194.4000 | ||||||
| Cash Flow from Investing Activities | -186.9780 | -208.8890 | -60.2500 | -784.4380 | -1,207.5930 | ||||||
| Cash Flow from Financing | -48.6800 | -22.7580 | -523.0410 | -55.4290 | 973.5760 | ||||||
| Decrease / Increase in Cash | 49.1810 | 228.4870 | 4.4640 | -195.9820 | -36.5890 | ||||||
| Employees | 8,260 | 8,120 | - | - | - | ||||||
